Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - cisplatin -

Belgium - Inggeris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - cisplatin 10 mg/10 ml - concentrate for solution for infusion - 1 mg/ml - cisplatin 1 mg/ml - cisplatin

Belgium - Inggeris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - cisplatin 10 mg/10 ml - concentrate for solution for infusion - 1 mg/ml - cisplatin 1 mg/ml - cisplatin

Belgium - Inggeris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - cisplatin 10 mg/10 ml - concentrate for solution for infusion - 1 mg/ml - cisplatin 1 mg/ml - cisplatin

Belgium - Inggeris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - cisplatin 10 mg/10 ml - concentrate for solution for infusion - 1 mg/ml - cisplatin 1 mg/ml - cisplatin

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - cisplatin 1 mg/ml - solution for injection - 1 mg/ml - active: cisplatin 1 mg/ml excipient: mannitol sodium chloride water for injection - dbl cisplatin injection is indicated for the palliative treatment of metastatic non-seminomatous germ cell carcinoma, advanced-stage refractory ovarian carcinoma, advanced-stage refractory bladder carcinoma and refractory squamous cell carcinoma of the head and neck. it may be used as a single agent or in combination with other chemotherapeutic agents. it may be employed, in appropriate circumstances, in addition to other modalities, e.g. radiotherapy or surgery.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, concentrated - excipient ingredients: sodium chloride; sodium hydroxide; water for injections; mannitol; hydrochloric acid - cisplatin is used in the treatment of certain types of cancer, for example ovarian cancer, testicular cancer, bladder cancer and head and neck cancer. cisplatin may be used in combination with other anti-cancer medicines.

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

rex medical ltd - cisplatin 1 mg/ml - solution for injection - 1 mg/ml - active: cisplatin 1 mg/ml excipient: hydrochloric acid sodium chloride water for injection - cisplatin injection is indicated for the palliative treatment of metastatic non-seminomatous germ cell carcinoma, advanced-stage refractory ovarian carcinoma, advanced-stage refractory bladder carcinoma and refractory squamous cell carcinoma of the head and neck. it may be used as a single agent or in combination with other chemotherapeutic agents. it may be employed, in appropriate circumstances, in addition to other modalities, eg radiotherapy or surgery.

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - cisplatin - concentrate for soln for inf - 0.5 mg/ml

Armenia - Inggeris - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

pharmachemie b.v. swensweg 5 - cisplatin - concentrate for solution for infusion - 0,5mg/ml